Indication
Presbyopia
Presbyopia is a common, progressive refractive condition characterized by the age-related decline in the eye's ability to focus on proximal objects. Read more about Presbyopia
2 drugs 2 manufacturers
Drugs that treat it
Common Presbyopia therapies.
YUVEZZI (carbachol/brimonidine tartrate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPresbyopia is a common, progressive refractive condition characterized by the age-related decline in the eye's ability to focus on proximal objects.
Primarily affecting middle-aged and older adults—typically manifesting after age 40—it is a physiological consequence of the natural ocular aging process.
Pathophysiologically, it results from the gradual sclerosis, loss of elasticity, and geometric changes of the crystalline lens, often accompanied by decreased contractility of the ciliary muscle fibers.
This loss of accommodative amplitude prevents dynamic optical power adjustments, causing light from near targets to focus behind the retina and producing classic symptoms such as blurred near vision, asthenopia, and headaches during reading or close-work tasks.
- nih.gov
Presbyopia is a common, progressive refractive condition characterized by the age-related decline in the eye's ability to focus on proximal objects Primarily affecting middle-aged and older adults—typically manifesting after age 40—it is a physiological consequence of the natural ocular aging process
- nih.gov
Presbyopia is a common, progressive refractive condition characterized by the age-related decline in the eye's ability to focus on proximal objects Primarily affecting middle-aged and older adults—typically manifesting after age 40—it is a physiological consequence of the natural ocular aging process Pathophysiologically, it results from the gradual sclerosis, loss of elasticity, and geometric changes of the crystalline lens, often accompanied by decreased contractility of the ciliary muscle fib...
- aao.org
Primarily affecting middle-aged and older adults—typically manifesting after age 40—it is a physiological consequence of the natural ocular aging process
- nih.gov
Pathophysiologically, it results from the gradual sclerosis, loss of elasticity, and geometric changes of the crystalline lens, often accompanied by decreased contractility of the ciliary muscle fibers This loss of accommodative amplitude prevents dynamic optical power adjustments, causing light from near targets to focus behind the retina and producing classic symptoms such as blurred near vision, asthenopia, and headaches during reading or close-work tasks
- nih.gov
Pathophysiologically, it results from the gradual sclerosis, loss of elasticity, and geometric changes of the crystalline lens, often accompanied by decreased contractility of the ciliary muscle fibers
Personalize your experience
Follow Presbyopia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.